AMJ GLOBAL TECHNOLOGY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.25 USD | -35.57% |
|
-.--% | -28.57% |
| Apr. 17 | AMJ Global Technology Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| Apr. 01 | Amj Global Technology Announces Executive Changes | CI |
Financials (USD)
| Sales 2022 | - | Sales 2023 | - | Capitalization | 155M |
|---|---|---|---|---|---|
| Net income 2022 | -2M | Net income 2023 | - | EV / Sales 2022 | - |
| Net Debt 2022 | 11.1K | Net Debt 2023 | 16.46K | EV / Sales 2023 | - |
| P/E ratio 2022 |
-54.5
x | P/E ratio 2023 |
-1,015
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.54% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -35.57% | ||
| 3 months | -34.21% | ||
| 6 months | -16.67% | ||
| Current year | -28.57% |
Current year
0.25
1.94
1 year
0.062.25
3 years
0.062.25
5 years
0.012.25
10 years
0.015.95
| Managers | Title | Age | Since |
|---|---|---|---|
Arthur Malone
CEO | Chief Executive Officer | 57 | 15-11-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Arthur Malone
CEO | Chief Executive Officer | 57 | 15-11-08 |
AMJ Global Technology is engaged in evaluating operations in the wholistic health industry. The Company is focusing on the intersection of technology and wholistic technology-based health treatments. The Company focuses on providing services to formulate a treatment model to meet the needs of professional athletes that suffer from post-traumatic stress disorder (PTSD) and the early onset of dementia and Alzheimerâs. The Company has not generated any revenue.
Sector
Software
| 1st Jan change | Capi. | |
|---|---|---|
| -28.57% | 130M | |
| +24.81% | 23.87B | |
| +8.59% | 2.6B | |
| -22.47% | 1.86B | |
| +80.82% | 1.82B | |
| -51.51% | 1.32B | |
| -1.02% | 1.36B | |
| +5.04% | 1.32B | |
| -19.15% | 1.24B | |
| +15.94% | 1.12B |
- Stock Market
- Equities
- AMJT Stock
